Skip Navigation LinksHome > June 2007 - Volume 21 - Issue 10 > Antiviral therapy for hepatitis C virus recurrence after liv...
doi: 10.1097/QAD.0b013e3280d5a79a
Research Letters

Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort

Wojcik, Kamilaa; Vogel, Martinb; Voigt, Estherb; Speidel, Nicolac; Kalff, Jörg Cc; Goldmann, Georgd; Oldenburg, Johannesd; Sauerbruch, Tilmanb; Rockstroh, Jürgen Kurtb; Spengler, Ulrichb

Collapse Box


Recurrent hepatitis C is a major cause of mortality in HIV/hepatitis C virus (HCV)-co-infected patients after orthotopic liver transplantation. We report sustained viral clearance in all four transplanted HIV/HCV-positive patients treated with pegylated interferon/ribavirin. Early therapy after HCV recurrence, tailoring treatment duration to the individual decline in HCV-RNA and the management of side effects are key factors for improved efficacy. At experienced centres interferon treatment is a valuable option for recurrent hepatitis C in HIV-positive patients.

© 2007 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics